BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6502474)

  • 1. Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog.
    Bai SA; Abramson FP
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):333-49. PubMed ID: 6502474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic drug interactions with propranolol.
    Wood AJ; Feely J
    Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing.
    Maskasame C; Lankford SM; Bai SA
    Drug Metab Dispos; 1993; 21(1):156-61. PubMed ID: 8095211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chlorpromazine, metyrapone, imipramine and SKF 525-A on the hepatic first pass elimination of propranolol in the pithed rat.
    Barber HE; Kitteringham NR; Petrie JC
    Br J Pharmacol; 1982 Dec; 77(4):667-77. PubMed ID: 7150874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of physical exercise on the pharmacokinetics of propranolol.
    Arends BG; Böhm RO; van Kemenade JE; Rahn KH; van Baak MA
    Eur J Clin Pharmacol; 1986; 31(3):375-7. PubMed ID: 3792439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of propranolol during pregnancy.
    O'Hare MF; Kinney CD; Murnaghan GA; McDevitt DG
    Eur J Clin Pharmacol; 1984; 27(5):583-7. PubMed ID: 6519163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
    Bai SA; Wilson MJ; Walle UK; Walle T
    J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
    Bax ND; Tucker GT; Lennard MS; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between oral hydralazine and propranolol. I. Changes in absorption, presystemic clearance and splanchnic blood flow.
    Heinzow B; Corbett H; Constantinides S; Bourne R; McLean AJ
    J Pharmacol Exp Ther; 1984 May; 229(2):509-14. PubMed ID: 6716273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM; Maskasame C; Bai SA
    Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme induction and beta-adrenergic receptor blocking drugs.
    Branch RA; Herman RJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of propranolol isomers and their relationships with beta adrenoceptor blocking activity in rabbits administered with dl-propranolol.
    Kawashima K; Ishikawa H
    J Pharmacol Exp Ther; 1980 Jun; 213(3):628-31. PubMed ID: 6110769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol.
    Niemann CU; Henthorn TK; Krejcie TC; Shanks CA; Enders-Klein C; Avram MJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):342-50. PubMed ID: 10801242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.